<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <atom:link href="https://feeds.megaphone.fm/DHT5077888106" rel="self" type="application/rss+xml"/>
    <title>IMPOSSIBLE HEALTHCARE</title>
    <link>http://www.impossiblehealthcare.com</link>
    <language>en-us</language>
    <copyright>℗ &amp; © 2019 IMPOSSIBLE HEALTHCARE</copyright>
    <description>Started by two physicians at Cedars-Sinai in Los Angeles, the Impossible Healthcare Podcast is a unique look into what is changing in healthcare. Join Dr. Sameer Berry &amp; Dr. Michael Albert as they sit down with thought leaders to discuss the most pressing topics in healthcare.</description>
    <image>
      <url>https://megaphone.imgix.net/podcasts/6a1eb58e-af61-11e9-b08c-d336f85a6701/image/a27a83a9b612582a6e32ea54eecf1458.jpeg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress</url>
      <title>IMPOSSIBLE HEALTHCARE</title>
      <link>http://www.impossiblehealthcare.com</link>
    </image>
    <itunes:explicit>no</itunes:explicit>
    <itunes:type>episodic</itunes:type>
    <itunes:subtitle>Dr. Sameer Berry &amp; Dr. Michael Albert sit down with thought leaders to discuss the most pressing topics in healthcare</itunes:subtitle>
    <itunes:author>Dr. Berry &amp; Dr. Albert</itunes:author>
    <itunes:summary>Started by two physicians at Cedars-Sinai in Los Angeles, the Impossible Healthcare Podcast is a unique look into what is changing in healthcare. Join Dr. Sameer Berry &amp; Dr. Michael Albert as they sit down with thought leaders to discuss the most pressing topics in healthcare.</itunes:summary>
    <content:encoded>
      <![CDATA[<p>Started by two physicians at Cedars-Sinai in Los Angeles, the Impossible Healthcare Podcast is a unique look into what is changing in healthcare. Join Dr. Sameer Berry &amp; Dr. Michael Albert as they sit down with thought leaders to discuss the most pressing topics in healthcare.</p>]]>
    </content:encoded>
    <itunes:owner>
      <itunes:name>Sameer Berry</itunes:name>
      <itunes:email>impossiblehealthcare@gmail.com</itunes:email>
    </itunes:owner>
    <itunes:image href="https://megaphone.imgix.net/podcasts/6a1eb58e-af61-11e9-b08c-d336f85a6701/image/a27a83a9b612582a6e32ea54eecf1458.jpeg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
    <itunes:category text="Science">
    </itunes:category>
    <itunes:category text="Health &amp; Fitness">
    </itunes:category>
    <itunes:category text="Technology">
    </itunes:category>
    <itunes:new-feed-url>https://feeds.megaphone.fm/DHT5077888106</itunes:new-feed-url>
    <item>
      <title>Chris Hogg - Propeller Health</title>
      <description>Chris Hogg has an incredibly diverse background. He studied molecular biology at Brown University, worked in a basic science lab, and then went to business school at Booth. Chris went on to work in healthcare investment banking and in biotech at Gilead before transitioning to digital health. He founded 100Plus, where he was able to successfully secure EMR data and government contracts to try and change human behavior. We discuss the challenges he faced at this startup and his eventual transition to Propeller Health, where he was the Chief Commercialization Officer.</description>
      <pubDate>Sun, 20 Sep 2020 23:05:00 -0000</pubDate>
      <itunes:title>Chris Hogg - Propeller Health</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>8</itunes:episode>
      <itunes:author>Dr. Berry &amp; Dr. Albert</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/7794fbd4-fb9a-11ea-9712-cb1c8ae6b22a/image/uploads_2F1600645395736-16gtt3kbaxn-930ef34cc76efe5cc00cbc7beabd28a2_2FImpossibleHealthPodcast.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Chris Hogg is the (former) Chief Commercialization Officer of Propeller Health </itunes:subtitle>
      <itunes:summary>Chris Hogg has an incredibly diverse background. He studied molecular biology at Brown University, worked in a basic science lab, and then went to business school at Booth. Chris went on to work in healthcare investment banking and in biotech at Gilead before transitioning to digital health. He founded 100Plus, where he was able to successfully secure EMR data and government contracts to try and change human behavior. We discuss the challenges he faced at this startup and his eventual transition to Propeller Health, where he was the Chief Commercialization Officer.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Chris Hogg has an incredibly diverse background. He studied molecular biology at Brown University, worked in a basic science lab, and then went to business school at Booth. Chris went on to work in healthcare investment banking and in biotech at Gilead before transitioning to digital health. He founded 100Plus, where he was able to successfully secure EMR data and government contracts to try and change human behavior. We discuss the challenges he faced at this startup and his eventual transition to Propeller Health, where he was the Chief Commercialization Officer.</p>]]>
      </content:encoded>
      <itunes:duration>3531</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[7794fbd4-fb9a-11ea-9712-cb1c8ae6b22a]]></guid>
      <enclosure url="https://www.podtrac.com/pts/redirect.mp3/traffic.megaphone.fm/DHT2844959335.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Sean Duffy - Omada Health</title>
      <description>Sean Duffy was in the MD/MBA program at Harvard when he left to start Omada Health, a digital health startup tackling chronic diseases like diabetes, obesity, and behavioral health. He leveraged his background in design-thinking from IDEO and technology from Google to build one of the most reputable startups in healthcare. We discuss how Omada has successfully sold to self-insured employers, embraced regulatory changes, estimated actuarial risk for value-based pricing, and applied AI to their data. Sean also talks about what's next for Omada, and what scale looks like for the company.
Omada Health is the largest CDC-recognized provider of the National Diabetes Prevention Program, was named a 2016 Technology Pioneer by the World Economic Forum, and one of Fast Company’s Most Innovative Companies in 2017.</description>
      <pubDate>Fri, 15 May 2020 17:36:00 -0000</pubDate>
      <itunes:title>Sean Duffy - Omada Health</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>7</itunes:episode>
      <itunes:author>Dr. Berry &amp; Dr. Albert</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/8ceaeab8-96d5-11ea-848f-abf47b8db8b7/image/uploads_2F1589565028153-f5ytzi34sy9-6346f34cb2d7c50a3d8b34e502eba579_2FDuffy+Wavve+image.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Sean Duffy is the CEO &amp; Co-Founder of Omada Health, a transformative digital health company, which has set the benchmark for startups in healthcare. </itunes:subtitle>
      <itunes:summary>Sean Duffy was in the MD/MBA program at Harvard when he left to start Omada Health, a digital health startup tackling chronic diseases like diabetes, obesity, and behavioral health. He leveraged his background in design-thinking from IDEO and technology from Google to build one of the most reputable startups in healthcare. We discuss how Omada has successfully sold to self-insured employers, embraced regulatory changes, estimated actuarial risk for value-based pricing, and applied AI to their data. Sean also talks about what's next for Omada, and what scale looks like for the company.
Omada Health is the largest CDC-recognized provider of the National Diabetes Prevention Program, was named a 2016 Technology Pioneer by the World Economic Forum, and one of Fast Company’s Most Innovative Companies in 2017.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Sean Duffy was in the MD/MBA program at Harvard when he left to start Omada Health, a digital health startup tackling chronic diseases like diabetes, obesity, and behavioral health. He leveraged his background in design-thinking from IDEO and technology from Google to build one of the most reputable startups in healthcare. We discuss how Omada has successfully sold to self-insured employers, embraced regulatory changes, estimated actuarial risk for value-based pricing, and applied AI to their data. Sean also talks about what's next for Omada, and what scale looks like for the company.</p><p>Omada Health is the largest CDC-recognized provider of the National Diabetes Prevention Program, was named a 2016 Technology Pioneer by the World Economic Forum, and one of Fast Company’s Most Innovative Companies in 2017.</p>]]>
      </content:encoded>
      <itunes:duration>2663</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[8ceaeab8-96d5-11ea-848f-abf47b8db8b7]]></guid>
      <enclosure url="https://www.podtrac.com/pts/redirect.mp3/traffic.megaphone.fm/DHT1786924487.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Neal Khosla - Why Startups Fail in Healthcare</title>
      <description>Neal Khosla is a serial entrepreneur with a background in computer science &amp; artificial intelligence from Stanford and Google. In this episode, we discuss the unique challenges of working with various stakeholders in healthcare including providers, payors, investors, regulators, and (most importantly) patients. Despite more than $30b invested in digital health since 2011, we have not seen major disruption. Neal has incredible insight into why patient experience has not improved and how startups can navigate these challenges.</description>
      <pubDate>Mon, 27 Apr 2020 16:22:00 -0000</pubDate>
      <itunes:title>Neal Khosla - Why Startups Fail in Healthcare</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>6</itunes:episode>
      <itunes:author>Dr. Berry &amp; Dr. Albert</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/8aa3e36a-88a5-11ea-8f62-8bce7e279573/image/uploads_2F1588005442348-4ugr6ylnfpj-6166b7e7e4ef142c2bb374a92ac65fa2_2FImpossible+Healthcare+Podcast+Graphic.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Neal Khosla is a serial entrepreneur with a background in computer science &amp; artificial intelligence from Stanford and Google. In this episode, we discuss the unique challenges of working with various stakeholders in healthcare including providers, payors, investors, regulators, and (most importantly) patients. Despite more than $30b invested in digital health since 2011, we have not seen major disruption. Neal has incredible insight into why patient experience has not improved and how startups can navigate these challenges.</itunes:subtitle>
      <itunes:summary>Neal Khosla is a serial entrepreneur with a background in computer science &amp; artificial intelligence from Stanford and Google. In this episode, we discuss the unique challenges of working with various stakeholders in healthcare including providers, payors, investors, regulators, and (most importantly) patients. Despite more than $30b invested in digital health since 2011, we have not seen major disruption. Neal has incredible insight into why patient experience has not improved and how startups can navigate these challenges.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Neal Khosla is a serial entrepreneur with a background in computer science &amp; artificial intelligence from Stanford and Google. In this episode, we discuss the unique challenges of working with various stakeholders in healthcare including providers, payors, investors, regulators, and (most importantly) patients. Despite more than $30b invested in digital health since 2011, we have not seen major disruption. Neal has incredible insight into why patient experience has not improved and how startups can navigate these challenges.</p>]]>
      </content:encoded>
      <itunes:duration>4463</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[8aa3e36a-88a5-11ea-8f62-8bce7e279573]]></guid>
      <enclosure url="https://www.podtrac.com/pts/redirect.mp3/traffic.megaphone.fm/DHT1009432247.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Dr. Brennan Spiegel (Cedars-Sinai) - Virtual Reality in Healthcare</title>
      <description>Dr. Spiegel is the Director of Health Services Research &amp; Clinical Transformation at the Cedars-Sinai Health System. He is also the Editor-in-Chief of the American Journal of Gastroenterology, the premiere GI journal. His lab, the Center for Outcomes Research, conducts research on how technology can improve healthcare and has received funding from the NIH, Veterans Affairs, and Robert-Wood Johnson Foundation. </description>
      <pubDate>Fri, 04 Oct 2019 02:06:14 -0000</pubDate>
      <itunes:title>Dr. Brennan Spiegel (Cedars-Sinai) - Virtual Reality in Healthcare</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>5</itunes:episode>
      <itunes:author>Dr. Berry &amp; Dr. Albert</itunes:author>
      <itunes:subtitle>We discuss how Dr. Spiegel used a scientific &amp; clinically-validated approach to implement a new technology in healthcare. </itunes:subtitle>
      <itunes:summary>Dr. Spiegel is the Director of Health Services Research &amp; Clinical Transformation at the Cedars-Sinai Health System. He is also the Editor-in-Chief of the American Journal of Gastroenterology, the premiere GI journal. His lab, the Center for Outcomes Research, conducts research on how technology can improve healthcare and has received funding from the NIH, Veterans Affairs, and Robert-Wood Johnson Foundation. </itunes:summary>
      <content:encoded>
        <![CDATA[<p>Dr. Spiegel is the Director of Health Services Research &amp; Clinical Transformation at the Cedars-Sinai Health System. He is also the Editor-in-Chief of the American Journal of Gastroenterology, the premiere GI journal. His lab, the Center for Outcomes Research, conducts research on how technology can improve healthcare and has received funding from the NIH, Veterans Affairs, and Robert-Wood Johnson Foundation. </p>]]>
      </content:encoded>
      <itunes:duration>2841</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[c9ef1344-e64a-11e9-be2e-fbf280ed614b]]></guid>
      <enclosure url="https://www.podtrac.com/pts/redirect.mp3/traffic.megaphone.fm/DHT4791142876.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Christina Farr (CNBC) - Tech Giants in Healthcare</title>
      <description>Christina's work in healthcare gives her a unique perspective on the entrance of tech giants to this industry. We discuss the challenges faced by these large companies entering healthcare, what opportunities they are missing, and failed examples. She also speaks about the common attributes she's noticed when interviewing successful founders/investors and what they are looking for.</description>
      <pubDate>Sat, 15 Jun 2019 15:00:00 -0000</pubDate>
      <itunes:title>Christina Farr (CNBC) - Tech Giants in Healthcare</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>4</itunes:episode>
      <itunes:author>Dr. Berry &amp; Dr. Albert</itunes:author>
      <itunes:subtitle>Chrissy Farr is one of the most reputable journalists covering healthcare. She writes for CNBC and has broken the biggest stories involving technology giants Facebook, Google, Amazon, and Apple</itunes:subtitle>
      <itunes:summary>Christina's work in healthcare gives her a unique perspective on the entrance of tech giants to this industry. We discuss the challenges faced by these large companies entering healthcare, what opportunities they are missing, and failed examples. She also speaks about the common attributes she's noticed when interviewing successful founders/investors and what they are looking for.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Christina's work in healthcare gives her a unique perspective on the entrance of tech giants to this industry. We discuss the challenges faced by these large companies entering healthcare, what opportunities they are missing, and failed examples. She also speaks about the common attributes she's noticed when interviewing successful founders/investors and what they are looking for.</p>]]>
      </content:encoded>
      <itunes:duration>2564</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[Buzzsprout-1281766]]></guid>
      <enclosure url="https://www.podtrac.com/pts/redirect.mp3/traffic.megaphone.fm/DHT2629911902.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Tom Priselac (CEO of Cedars-Sinai) - Implementing AI</title>
      <description>Tom Priselac has been the CEO of Cedars-Sinai for 25 years and overseen unprecedented transitions for the organization. As chair of the American Hospital Association he was also closely involved with President Obama in developing the ACA. We discuss his role in evaluating new technologies and what metrics they use in deciding which technologies to implement at Cedars. Mr. Priselac also discusses how he fits in time for learning and advice for startups looking to make an impact in healthcare.</description>
      <pubDate>Sun, 14 Apr 2019 22:00:00 -0000</pubDate>
      <itunes:title>Tom Priselac (CEO of Cedars-Sinai) - Implementing AI</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>3</itunes:episode>
      <itunes:author>Dr. Berry &amp; Dr. Albert</itunes:author>
      <itunes:subtitle>The President &amp; CEO of Cedars-Sinai, the largest private non-profit health system in the West, discusses the practicality of how to implement AI into the clinical trenches</itunes:subtitle>
      <itunes:summary>Tom Priselac has been the CEO of Cedars-Sinai for 25 years and overseen unprecedented transitions for the organization. As chair of the American Hospital Association he was also closely involved with President Obama in developing the ACA. We discuss his role in evaluating new technologies and what metrics they use in deciding which technologies to implement at Cedars. Mr. Priselac also discusses how he fits in time for learning and advice for startups looking to make an impact in healthcare.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Tom Priselac has been the CEO of Cedars-Sinai for 25 years and overseen unprecedented transitions for the organization. As chair of the American Hospital Association he was also closely involved with President Obama in developing the ACA. We discuss his role in evaluating new technologies and what metrics they use in deciding which technologies to implement at Cedars. Mr. Priselac also discusses how he fits in time for learning and advice for startups looking to make an impact in healthcare.</p>]]>
      </content:encoded>
      <itunes:duration>2238</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[Buzzsprout-1038837]]></guid>
      <enclosure url="https://www.podtrac.com/pts/redirect.mp3/traffic.megaphone.fm/DHT4634700729.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Dr. Califf (FDA Commissioner) - Regulating AI </title>
      <description>Dr. Rob Califf is the former Commissioner of the Food &amp; Drug Administration (FDA), founding director of the world's largest academic research organization - the Duke Clinical Research Institute, and a professor at Duke and Stanford. He is one of the top 10 most cited medical authors, with more than 1,200 publications. Dr. Califf is also a senior health advisor for Google's life sciences division, Verily. We discuss the regulation of medical technology and the challenges of regulating AI.</description>
      <pubDate>Thu, 11 Apr 2019 07:00:00 -0000</pubDate>
      <itunes:title>Dr. Califf (FDA Commissioner) - Regulating AI </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>2</itunes:episode>
      <itunes:author>Dr. Berry &amp; Dr. Albert</itunes:author>
      <itunes:subtitle>A conversation with the former FDA Commissioner on the unique challenges of regulating AI in healthcare</itunes:subtitle>
      <itunes:summary>Dr. Rob Califf is the former Commissioner of the Food &amp; Drug Administration (FDA), founding director of the world's largest academic research organization - the Duke Clinical Research Institute, and a professor at Duke and Stanford. He is one of the top 10 most cited medical authors, with more than 1,200 publications. Dr. Califf is also a senior health advisor for Google's life sciences division, Verily. We discuss the regulation of medical technology and the challenges of regulating AI.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Dr. Rob Califf is the former Commissioner of the Food &amp; Drug Administration (FDA), founding director of the world's largest academic research organization - the Duke Clinical Research Institute, and a professor at Duke and Stanford. He is one of the top 10 most cited medical authors, with more than 1,200 publications. Dr. Califf is also a senior health advisor for Google's life sciences division, Verily. We discuss the regulation of medical technology and the challenges of regulating AI.</p>]]>
      </content:encoded>
      <itunes:duration>1979</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[Buzzsprout-1035386]]></guid>
      <enclosure url="https://www.podtrac.com/pts/redirect.mp3/traffic.megaphone.fm/DHT8255853886.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Dr. Eric Topol - AI Overview</title>
      <description>Episode 1 of a three-part series on artificial intelligence (AI) in healthcare. Dr. Eric Topol is the former chair of cardiology at Cleveland Clinic, best-selling author, and now director of the Scripps Translational Research Institute. We discuss current uses of AI in healthcare, future hurdles, social media, his personal story, and advice for early-stage physicians!</description>
      <pubDate>Fri, 15 Mar 2019 07:00:00 -0000</pubDate>
      <itunes:title>Dr. Eric Topol - AI Overview</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>1</itunes:episode>
      <itunes:author>Dr. Berry &amp; Dr. Albert</itunes:author>
      <itunes:subtitle>An overview of artificial intelligence (A.I.) in healthcare with a leader in the field, Dr. Eric Topol</itunes:subtitle>
      <itunes:summary>Episode 1 of a three-part series on artificial intelligence (AI) in healthcare. Dr. Eric Topol is the former chair of cardiology at Cleveland Clinic, best-selling author, and now director of the Scripps Translational Research Institute. We discuss current uses of AI in healthcare, future hurdles, social media, his personal story, and advice for early-stage physicians!</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Episode 1 of a three-part series on artificial intelligence (AI) in healthcare. Dr. Eric Topol is the former chair of cardiology at Cleveland Clinic, best-selling author, and now director of the Scripps Translational Research Institute. We discuss current uses of AI in healthcare, future hurdles, social media, his personal story, and advice for early-stage physicians!</p>]]>
      </content:encoded>
      <itunes:duration>1817</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[Buzzsprout-996753]]></guid>
      <enclosure url="https://www.podtrac.com/pts/redirect.mp3/traffic.megaphone.fm/DHT1503333851.mp3" length="0" type="audio/mpeg"/>
    </item>
  </channel>
</rss>
